The DOI matches its Crossref record; 109 of the 110 references it cites were found in a registry or an index.
Virus contaminations of cell cultures – A biotechnological view
Open accessAbstract
In contrast to contamination by microbes and mycoplasma, which can be relatively easily detected, viral contamination present a serious threat because of the difficulty in detecting some viruses and the lack of effective methods of treating infected cell cultures. While some viruses are capable of causing morphological changes to infected cells (e.g. cytopathic effect) which are detectable by microscopy some viral contaminations result in the integration of the viral genome as provirus, this causes no visual evidence, by means of modification of the cellular morphology. Virus production from such cell lines, are potentially dangerous for other cell cultures (in research labs)by cross contaminations, or for operators and patients (in the case of the production of injectable biologicals) because of potential infection. The only way to keep cell cultures for research, development, and the biotech industry virus-free is the prevention of such contaminations. Cell cultures can become contaminated by the following means: firstly, they may already be contaminated as primary cultures (because the source of the cells was already infected), secondly, they were contaminated due to the use of contaminated raw materials, or thirdly, they were contaminated via an animal passage. This overview describes the problems and risks associated with viral contaminations in animal cell culture, describes the origins of these contaminations as well as the most important virsuses associated with viral contaminations in cell culture. In addition, ways to prevent viral contaminations as well as measures undertaken to avoid and assess risks for viral contaminations as performed in the biotech industry are briefly described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal-derived raw materials (ADRMs), especially serum, carry a relatively higher risk of being contaminated with virus and are thus being replaced where possible throughout the industry 1,9,13 .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the 20 th century several vaccine products were unintentionally contaminated with unwanted viruses during their production [1][2][3] .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Viruses are of particular concern as they are often more difficult to detect than other microbial contaminants 1 .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nishizawa, T., Okamoto, H., Konishi, K., Yoshizawa, H., Miyakawa, Y., & Mayumi, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7765 · Cited by 1,234
A very small porcine virus with circular single-stranded DNA
Tischer, I., Gelderblom, H., Vettermann, W., & Koch, M. A. (1982) · Nature · doi:10.1038/295064a0 · Cited by 786
Enders, J. F., Weller, T. H., & Robbins, F. C. (1949) · Science · doi:10.1126/science.109.2822.85 · Cited by 755
Sweet, B. H., & Hilleman, M. R. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-105-26128 · Cited by 523
Isolation and Some Characteristics of an Agent Inducing Anemia in Chicks
Yuasa, N., Taniguchi, T., & Yoshida, I. (1979) · Avian Diseases · doi:10.2307/1589567 · Cited by 351
The Intracisternal A-Particle Gene Family: Structure and Functional Aspects
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60223-7 · Cited by 340
HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12
SHAH, K., & NATHANSON, N. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112197 · Cited by 339
Klein, G., Dombos, L., & Gothoskar, B. (1972) · International Journal of Cancer · doi:10.1002/ijc.2910100108 · Cited by 297
Tumors Induced in Hamsters by Injection of Rhesus Monkey Kidney Cell Extracts
Eddy, B. E., Borman, G. S., Berkeley, W. H., & Young, R. D. (1961) · Experimental Biology and Medicine · doi:10.3181/00379727-107-26576 · Cited by 162
O'Connor, B., Gauvreau, H., West, K. I., Bogdan, J. R., Ayroud, M., Clark, E. G., Konoby, C., Allan, G., & Ellis, J. A. (2001) · Europe PMC (PubMed Central) · Cited by 154
Research works printed but not linked: 5
- Falcone E, Tollis M and Conti G (2000) Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 18: 387–388.
- Hansen G and Foster L (1997) Viral safety in serum for cell culture use. Art to Science 16: 1–7.
- Hoggan MD (1970) Adenovirus associated virus. Progr Med Virol 12: 211–239.
- Hoggan MD, Thomas GF and Johnson FB (1972) Continuous 'carriage' of adenovirus-associated virus genome in cell culture in the absence of helper adenovirus. In: 'The Proceedings of the 4th Lepetit Colloquium' (pp. 243–249), North Holland Publishing, Amsterdam, The Netherlands.
- Sprössig M and Mücke H (1967) Ñber die antimikrobielle Wirkung der Peressigsäure. 5. Mitteilung: Untersuchung zur viruziden Wirkung. Pharmazie 23: 665–667.
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 2,017
Rabbani, G., & Ahn, S. N. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.053 · Cited by 513
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371
Self-citationReview of the Current Research on Fetal Bovine Serum and the Development of Cultured Meat
Lee, D. Y., Lee, S. Y., Yun, S. H., Jeong, J. W., Kim, J. H., Kim, H. W., Choi, J., Kim, G., Joo, S.-T., Choi, I., et al. (2022) · Food Science of Animal Resources · doi:10.5851/kosfa.2022.e46 · Cited by 274
Advances in biodegradable and injectable hydrogels for biomedical applications
Li, Y., Yang, H. Y., & Lee, D. S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.008 · Cited by 261
Metadata
- Authors
- Merten, O.-W.
- Affiliations
- Genethon (France) (FR)
- Corresponding author
- Merten, O.-W.
- ORCID
- Merten, O.-W.
- Venue
- Cytotechnology
- Published
- 2002-06
- Volume
- 39
- Issue
- 2
- Pages
- 91-116
- ISSN
- 0920-9069 (ISSN-L)
- 1573-0778
- PMC
- PMC3463984
- OpenAlex
- W2153805979
- Cited by
- 133
- References
- 110
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 14 · 2019: 10 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 9 · 2013: 5
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Cytotechnology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- viral contamination, cell culture contamination, animal cell culture, provirus integration, cytopathic effect, cross-contamination, animal passage, contamination prevention, risk assessment, biotechnology industry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
